Alzheimer’s drug granted accelerated approval by FDA. These are the risks

Home » Top Stories » Alzheimer’s drug granted accelerated approval by FDA. These are the risks

CNN’s Sanjay Gupta reports the US Food and Drug Administration granted accelerated approval for the Alzheimer’s disease drug Lecanemab, one of the first experimental dementia drugs to appear to slow the progression of cognitive decline.

Categories:

Related Posts

FDA clears the way for additional bivalent boosters for certain vulnerable individuals
The U.S. Food and Drug Administration amended the terms of its emergency use authorizations for
Repeated gunshots fired on live TV as ex-lawmaker shot by assassins
Atiq Ahmed, a former lawmaker in India's parliament, convicted of kidnapping, was shot dead along
US warns Russia not to touch American nuclear technology at Ukrainian nuclear plant
The US has sensitive nuclear technology at a nuclear power plant inside Ukraine and is